Have a personal or library account? Click to login
Gave Syndrome – A Rare and Mysterious Cause of Gastrointestinal Hemorrhage in the Elderly Cover

Gave Syndrome – A Rare and Mysterious Cause of Gastrointestinal Hemorrhage in the Elderly

Open Access
|Sep 2019

References

  1. 1. Rider, JA; Klotz, AP; Kirsner, JB (1953). “Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage”. Gastroenterology. 24 (1): 118-23.10.1016/S0016-5085(53)80070-3
  2. 2. Rider, JA; Klotz, AP; Kirsner, JB (1953). “Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage”. Gastroenterology. 24 (1): 118-23.1305217010.1016/S0016-5085(53)80070-3
  3. 3. Jabbari M, Cherry R, Lough JO, Daly DS, Kinnear DG, Goresky CA. Gastric antrovascular ectasia: the watermelon stomach. Gastroenterology 1984;87:1165.10.1016/S0016-5085(84)80080-3
  4. 4. Ward EM, Raimondo M, Rosser BG, et al. Prevalence and natural history of gastric antral vascular ectasia (GAVE) in patients undergoing orthoptic liver transplantation. Journal of Clinical Gastroenterology. 2004;38:898-90010.1097/00004836-200411000-00013
  5. 5. C. J.Gostout, T. R.Viggiano, D. A. Ahlquist, K. K.Wang, M. V. Larson, and R. Balm, “The clinical and endoscopic spectrum of the watermelon stomach,” Journal of Clinical Gastroenterology, vol. 15, no. 3, pp. 256–263, 199210.1097/00004836-199210000-00019
  6. 6. E. Quintero, J.M. Pique, J.A. Bombi et al., “Gastricmucosal vascular ectasias causing bleeding in cirrhosis: a distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I,” Gastroenterology, vol. 93, no. 5, pp. 1054–1061, 1987.10.1016/0016-5085(87)90569-5
  7. 7. J. R. Lowes and J. Rode, “Neuroendocrine cell proliferations in gastric antral vascular ectasia,” Gastroenterology, vol. 97, no. 1, pp. 207–212, 1989.10.1016/0016-5085(89)91437-6
  8. 8. Gostout CJ, Viggiano TR, Ahlquist DA, Wang KK, Larson MV, Balm R. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterology 1992;15:256-263.10.1097/00004836-199210000-00019
  9. 9. Payen JL, Cales P, Voigt JJ, Payen JL, Calès P, Voigt JJ, Barbe S, Pilette C, Dubuisson L, Desmorat H, Vinel JP, Kervran A, Chayvialle JA. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology 1995;108:138–144.10.1016/0016-5085(95)90018-7
  10. 10. Yusoff I, Brennan F, Ormonde D, Laurence B. Argon plasma coagulation for the treatment of watermelon stomach. Endoscopy. 2002;34:407-4101197227410.1055/s-2002-2528711972274
  11. 11. Roman S, Saurin JC, Dumortier J, et al. Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach. Endoscopy. 2003;35:1024-102810.1055/s-2003-44594
  12. 12. Cho S, Zanati S, Yong E, et al. Endoscopic cryotherapy for the management of gastric antral vascular ectasia. Gastrointestinal Endoscopy. 2008;68:895-90210.1016/j.gie.2008.03.1109
  13. 13. Wahab PJ, Mulder CJ, den Hartog G, Thies JE. Argon plasma coagulation in flexible gastrointestinal endoscopy: Pilot experiences. Endoscopy 1997;29:176-18110.1055/s-2007-1004159
  14. 14. Jackson CS, Gerson LB. Management of gastrointestinal angiodysplastic lesions (GIADs): A systematic review and meta-analysis. American Journal of Gastroenterology. 2014;109:474-48310.1038/ajg.2014.19
  15. 15. Nardone G, Rocco A, Balzano T. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Alimentary Pharmacology & Therapeutics. 1999;13:1429-136310.1046/j.1365-2036.1999.00647.x
  16. 16. Li SC, Martijn C, Cui T, et al. The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells. PloS One. 2012;7:e4841110.1371/journal.pone.0048411
  17. 17. Zalatnai A, Timar F. Vitro antiangiogenic effect of sandostatin (octreotide) on the proliferation of the placental vessels. Anticancer Research. 2002;22:4225-4227
  18. 18. D. A. Papachristos, M. Nikpour, C. Hair, and W. M. Stevens, “Intravenous cyclophosphamide as a therapeutic option for severe refractory gastric antral vascular ectasia in systemic sclerosis,” Internal Medicine Journal, vol. 45, no. 10, pp. 1077–1081, 2015.10.1111/imj.12883
  19. 19. Bhowmick BK. Watermelon stomach treated with oral corticosteroid. Journal of the Royal Society of Medicine. 1993;86:52
  20. 20. McCormick PA, Ooi H, Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut. 1998;42:750-75210.1136/gut.42.5.750
  21. 21. Dunne KA, Hill J, Dillon JF. Treatment of chronic transfusion-dependent gastric antral vascular ectasia (watermelon stomach) with thalidomide. European Journal of Gastroenterology & Hepatology. 2006;18:455-45610.1097/00042737-200604000-00024
  22. 22. Cabral JE, Pontes JM, Toste M, et al. Watermelon stomach: Treatment with a serotonin antagonist. American Journal of Gastroenterology. 1991;86:927-928
  23. 23. Novitsky YW, Kercher KW, Czerniach DR, Litwin DE. Watermelon stomach: Pathophysiology, diagnosis, and management. Journal of Gastrointestinal Surgery. 2003;7:652-66110.1016/S1091-255X(02)00435-3
DOI: https://doi.org/10.2478/inmed-2019-0079 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 73 - 82
Published on: Sep 28, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Alina Simache, Alice Bălăceanu, Cornelia Voiculeţ, Secil Omer, Ion Dina, Magda Ruxandra Zaharia, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.